Endometrial Hyperplasia

Endometrial Hyperplasia


INTRODUCTION:

  • Endometrial hyperplasia is overgrowth of uterine lining (endometrium) that may progress to or coexist with endometrial (uterine) cancer.
  • Long-term unopposed estrogen production causes overgrowth of the uterine lining and results in endometrial hyperplasia.
  • Atypical endometrial hyperplasia undergoes malignant transformation in 25%

RISK FACTORS:

  • Obesity
  • Polycystic Ovarian Syndrome
  • Estrogen therapy without progesterone
  • Estrogen-secreting ovarian tumors
  • Tamoxifen 

TYPES:

  • Simple without atypia: One percent risk of uterine cancer.
  • Complex without atypia: Three percent risk of uterine cancer.
  • Simple with atypia: Eight percent risk of uterine cancer.
  • Complex with atypia: 
  • The most significant type of endometrial hyperplasia. 
  • 29% progress to uterine cancer and 17 to 59% of cases have coexistent uterine cancer.

SYMPTOMS:

  • Endometrial hyperplasia typically causes abnormal uterine bleeding and most commonly occurs in post-menopausal women.

DIAGNOSIS:

  • Biopsy without hysteroscopy:blind biopsy. A thin plastic tube is inserted into the uterus, and a small sample of the lining is obtained.
  • Biopsy with hysteroscopy :thin camera being guided into the uterine cavity and a small biopsy obtained
  • Hysteroscopy, D&C is performed in the operating room under anesthesia

TREATMENT:

  • Hysterectomy (removal of the uterus) is recommended for patients who are post-menopausal or patients who have completed childbearing.

Hyperplasia without atypia

  • Progesterone therapy
  • Depo Provera (injection)
  • IUD (Intrauterine device)

Hyperplasia with atypia

  • D&C should be performed to confirm the absence of cancer 
  • High-dose oral progesterone therapy 
  • Persistent hyperplasia after treatment for nine months is considered treatment failure and hysterectomy should be considered.
Exam Question
 
  • Endometrial hyperplasia is seen in PCOD cervix
  • Treatment of choice in a postmenopausal lady with atypical endometrial hyperplasia is Hysterectomy
  • Atypical endometrial hyperplasia undergoes malignant transformation in 25%
  • Endometrial hyperplasia  is indication for using endogenous progesterone
  • Estrogen causes endometrial hyperplasia
  • The risk of endometrial carcinoma is highest with  Complex hyperplasia with atypia
  • Tamoxifen causes Endometrial hyperplasia
Don’t Forget to Solve all the previous Year Question asked on Endometrial Hyperplasia

Leave a Reply

Discover more from New

Subscribe now to keep reading and get access to the full archive.

Continue reading

👨‍⚕️
Chat Support